This website is also available in English (Australia & NZ)

Patient engagement with myAir

myAir promotes patient engagement and encourages long-term compliance with sleep apnoea therapy by empowering patients to access and understand their sleep data. It’s easy for patients to lose interest or quit at the first hurdle when they feel like passive recipients of prescribed therapy.

myAir encourages patients to track their sleep therapy performance nightly and over time and shows them how they can improve their scores in key areas like leak management and usage time. Patients also receive regular coaching, encouragement and congratulations by text or email and have access to a video library with helpful advice and information. An increase in engagement can drive significant change. For example, research1 in Europe shows that myAir patients use their device for an average of 46 minutes more per night than other patients. Furthermore, adherence to CPAP treatment during the first week averaged 76% for myAir patients compared to 71% for other patients. Research in the US2 shows that patients who use myAir have a mean daily PAP usage of 5.9 hours against just 4.9 hours for patients who don’t use myAir.

As well as promoting patient engagement, myAir is part of a wider shift towards collaborative therapy. Remote monitoring solutions, like AirView , allow physicians to access, interpret and act upon their patients’ data at a distance. They’re designed to make it easy to share information and advice with other medical professionals. With the right information at the right time, both patients and professionals are able to make good decisions and communicate effectively.

Empower your patients with myAir and you’ll be supporting their efforts to achieve long-term compliance and benefit from better health.

References: 

  1. Price Waterhouse Coopers. Empowering the sleep apnoea patient: A study of how myAir users behave better. 2016. 
  2. Malhotra A et al. Patient Engagement Using New Technology to Improve Adherence to Positive Airway Pressure Therapy. Chest 2018.